Insider · CIK 0001184228

PERLMUTTER ROGER M

Reports to the SEC for 5 companies · MILLBRAE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001184228

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-02	EIKNEikon Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See remarks	AAward	+268K sh	—	—	268,176
2026-02-06	EIKNEikon Therapeutics, Inc.C Conversion	Director, See remarks	CConversion	+285K sh	—	—	284,857
2026-02-06	EIKNEikon Therapeutics, Inc. · Series A-1 Preferred StockC Conversion	Director, See remarks	CConversion	−1.27M sh	—	—	0
2026-02-06	EIKNEikon Therapeutics, Inc. · Series D Preferred StockC Conversion	Director, See remarks	CConversion	−856K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−78.4K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24.2K sh	—	—	0
2024-04-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−46.2K sh	—	—	0
2023-05-10	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+78.4K sh	—	—	78,407
2022-05-18	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+24.2K sh	—	—	24,222
2021-06-08	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+46.2K sh	—	—	46,238
2020-05-01	MRKMerck & Co., Inc. · Stock Option (Right to Buy)A Award	Exe V-P & Pres, MRL	AAward	+151K sh	—	—	151,029
2020-02-28	MRKMerck & Co., Inc.A Award	Exe V-P & Pres, MRL	AAward	+35K sh	$76.56	+$2.68M	214,428.496
2019-05-03	MRKMerck & Co., Inc. · Stock Option (right to buy)A Award	Exe V-P & Pres, MRL	AAward	+141K sh	—	—	141,134
2019-02-25	MRKMerck & Co., Inc.A Award	Exe V-P & Pres, MRL	AAward	+32.9K sh	$80.38	+$2.65M	175,335.921
2018-11-08	MRKMerck & Co., Inc.M Exercise/Conversion	Exe V-P & Pres, MRL	MExercise/Conversion	+225K sh	$44.98	+$10.1M	366,997.968
2018-11-08	MRKMerck & Co., Inc.S Sale	Exe V-P & Pres, MRL	SSale	−225K sh	$75.27	−$17M	141,554.968
2018-11-08	MRKMerck & Co., Inc. · Stock Option (right to buy)M Exercise/Conversion	Exe V-P & Pres, MRL	MExercise/Conversion	−225K sh	—	—	0
2018-05-04	MRKMerck & Co., Inc. · Stock Option (right to buy)A Award	Exe V-P & Pres, MRL	AAward	+146K sh	—	—	146,383
2018-02-27	MRKMerck & Co., Inc.A Award	Exe V-P & Pres, MRL	AAward	+34.9K sh	$54.72	+$1.91M	138,906.628
2017-05-05	MRKMerck & Co., Inc. · Stock Option (right to buy)A Award	Exe V-P & Pres, MRL	AAward	+171K sh	—	—	171,184
2017-02-27	MRKMerck & Co., Inc.A Award	Exe V-P & Pres, MRL	AAward	+32.7K sh	$65.85	+$2.15M	101,601.221
2016-05-10	MRKMerck & Co., Inc. · Stock Option (right to buy)A Award	Exe V-P & Pres, MRL	AAward	+272K sh	—	—	271,647
2016-05-06	MRKMerck & Co., Inc.M Exercise/Conversion	Exe V-P & Pres, MRL	MExercise/Conversion	+44.5K sh	—	—	94,899.392
2016-05-06	MRKMerck & Co., Inc.F Tax Payment	Exe V-P & Pres, MRL	FTax Payment	−26.9K sh	$54.09	−$1.46M	67,953.392
2016-05-06	MRKMerck & Co., Inc. · Restricted Stock UnitM Exercise/Conversion	Exe V-P & Pres, MRL	MExercise/Conversion	−44.5K sh	$54.09	−$2.41M	0
2016-02-22	MRKMerck & Co., Inc.A Award	Exe V-P & Pres, MRL	AAward	+25.2K sh	$50.77	+$1.28M	50,227
2015-05-01	MRKMerck & Co., Inc. · Stock Option (right to buy)A Award	Exe V-P & Pres, MRL	AAward	+248K sh	—	—	247,678
2013-05-06	MRKMerck & Co., Inc. · Restricted Stock UnitA Award	Exe V-P & Pres, MRL	AAward	+44.5K sh	—	—	44,464
2013-05-06	MRKMerck & Co., Inc. · Stock Option (right to buy)A Award	Exe V-P & Pres, MRL	AAward	+225K sh	—	—	225,443
2012-12-14	MBOTMicrobot Medical Inc.A Award	Director	AAward	+10K sh	—	—	13,000
2012-02-02	AMGNAMGEN INCM Exercise/Conversion	EVP, Research & Development	MExercise/Conversion	+75K sh	$58.61	+$4.4M	261,031
2012-02-02	AMGNAMGEN INCS Sale	EVP, Research & Development	SSale	−75K sh	$69.83	−$5.24M	186,031
2012-02-02	AMGNAMGEN INC · Nqso (Right to Buy)M Exercise/Conversion	EVP, Research & Development	MExercise/Conversion	−75K sh	—	—	0
2011-12-14	MBOTMicrobot Medical Inc.A Award	Director	AAward	+1,000 sh	—	—	3,000
2011-04-29	AMGNAMGEN INCF Tax Payment	EVP, Research & Development	FTax Payment	−1,357 sh	$57.14	−$77.5K	186,031
2011-04-28	AMGNAMGEN INCF Tax Payment	EVP, Research & Development	FTax Payment	−1,357 sh	$56.82	−$77.1K	187,388
2011-04-26	AMGNAMGEN INCF Tax Payment	EVP, Research & Development	FTax Payment	−1,357 sh	$54.69	−$74.2K	188,745
2011-04-25	AMGNAMGEN INCA Award	EVP, Research & Development	AAward	+15.8K sh	—	—	190,102
2011-04-25	AMGNAMGEN INC · Nqso (Right to Buy)A Award	EVP, Research & Development	AAward	+55.1K sh	$54.69	+$3.01M	55,125
2011-03-11	AMGNAMGEN INCF Tax Payment	EVP, Research & Development	FTax Payment	−8,179 sh	$51.84	−$424K	174,302
2011-03-02	AMGNAMGEN INCA Award	EVP, Research & Development	AAward	+17.5K sh	—	—	182,481
2010-12-14	MBOTMicrobot Medical Inc.A Award	Director	AAward	+10K sh	—	—	20,000
2010-04-29	AMGNAMGEN INCF Tax Payment	EVP, Research & Development	FTax Payment	−1,401 sh	$58.18	−$81.5K	164,961
2010-04-28	AMGNAMGEN INCF Tax Payment	EVP, Research & Development	FTax Payment	−1,401 sh	$57.84	−$81K	166,362
2010-04-26	AMGNAMGEN INCA Award	EVP, Research & Development	AAward	+12K sh	—	—	167,763
2010-04-26	AMGNAMGEN INC · Nqso (Right to Buy)A Award	EVP, Research & Development	AAward	+84K sh	$58.43	+$4.91M	84,000
2010-03-12	AMGNAMGEN INCA Award	EVP, Research & Development	AAward	+12.3K sh	—	—	161,516
2010-03-12	AMGNAMGEN INCF Tax Payment	EVP, Research & Development	FTax Payment	−5,753 sh	$57.49	−$331K	155,763
2009-12-14	MBOTMicrobot Medical Inc.A Award	Director	AAward	+10K sh	—	—	10,000
2009-06-02	AMGNAMGEN INCM Exercise/Conversion	EVP, Research & Development	MExercise/Conversion	+2,609 sh	$38.36	+$100K	151,801

Recent filings

Accepted (ET)
Mar 44
PERLMUTTER ROGER M0001193125-26-091779
SEC(opens sec.gov)
Feb 104
PERLMUTTER ROGER M0001193125-26-044903
SEC(opens sec.gov)
Apr 84
PERLMUTTER ROGER M0000950170-24-042588
SEC(opens sec.gov)
May 124
PERLMUTTER ROGER M0001209191-23-029183
SEC(opens sec.gov)
May 204
PERLMUTTER ROGER M0001209191-22-031135
SEC(opens sec.gov)
Jun 104
PERLMUTTER ROGER M0001209191-21-039585
SEC(opens sec.gov)
May 54
PERLMUTTER ROGER M0001127602-20-015456
SEC(opens sec.gov)
Mar 34
PERLMUTTER ROGER M0001127602-20-009162
SEC(opens sec.gov)
May 74
PERLMUTTER ROGER M0001104659-19-027586
SEC(opens sec.gov)
Feb 274
PERLMUTTER ROGER M0001225208-19-003897
SEC(opens sec.gov)
Nov 84
PERLMUTTER ROGER M0001225208-18-015318
SEC(opens sec.gov)
May 84
PERLMUTTER ROGER M0001225208-18-008939
SEC(opens sec.gov)
Mar 14
PERLMUTTER ROGER M0001225208-18-005011
SEC(opens sec.gov)
May 94
Merck & Co., Inc.0001225208-17-009428
SEC(opens sec.gov)

Companies

Address

C/O EIKON THERAPEUTICS, INC. 230 HARRIET TUBMAN WAY

MILLBRAE, CA, 94030